Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-05 10:55 am Unchanged | 2024-04-05 | 13D | NGM Biopharmaceuticals, Inc. NGM | COLUMN GROUP L P | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-26 5:16 pm Unchanged | 2024-02-26 | 13D | NGM Biopharmaceuticals, Inc. NGM | COLUMN GROUP L P | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-12-29 4:05 pm Unchanged | 2023-12-29 | 13D | NGM Biopharmaceuticals, Inc. NGM | COLUMN GROUP L P | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-06-10 4:14 pm Unchanged | 2022-06-10 | 13D | NGM Biopharmaceuticals, Inc. NGM | COLUMN GROUP L P | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-11 4:34 pm Unchanged | 2022-02-11 | 13G | Nurix Therapeutics, Inc. NRIX | COLUMN GROUP L P | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-03 5:23 pm Unchanged | 2022-02-03 | 13D | NGM Biopharmaceuticals, Inc. NGM | COLUMN GROUP L P | 0 0.000% | 0 (Unchanged) | Filing |